SavedAdd your journal

Journals / Communications Faculty of Sciences University of Ankara Series C Biology / 2010 / Cilt: 22 - Sayı: 1

COBALT AND ASCORBIC ACID TREATMENT: EFFECTS ON TISSUE NITRIC OXIDE LEVELS IN STREPTOZOTOCIN- DIABETIC RAT

Özlem YILDIRIM
Pages
1–14
Publication Date
2010-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, the effect of oral administration of cobalt treatment may prove effective in improving the impaired nitrite status during the early stage of diabetes and ascorbic acid supplementation at this dose (1g/l) potentiates the effectiveness of cobalt action

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Öz The aim of present study was to determine the effect of cobalt (II) chloride (CoCl2) and CoCl2plus ascorbic acid (AA) on liver and kidney nitric oxide level at different stage of diabetes.
📊
Key Findings & Data:Three days after streptozotocin (STZ) injection, rats were divided into six groups: control, diabetic, control and diabetic treated with cobalt chloride, control and diabetics treated with cobalt chloride plus ascorbic acid. 0.5 mM CoCl2 or 0.5 mM CoCl2 plus 1 g/l ascorbic acid were added to their drinking water daily.
💡
Conclusion & Impact:Thus, the effect of oral administration of cobalt treatment may prove effective in improving the impaired nitrite status during the early stage of diabetes and ascorbic acid supplementation at this dose (1g/l) potentiates the effectiveness of cobalt action
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anahtar Kelimeler Nitric oxide · diabetes · cobalt

Özet

Öz The aim of present study was to determine the effect of cobalt (II) chloride (CoCl2) and CoCl2plus ascorbic acid (AA) on liver and kidney nitric oxide level at different stage of diabetes. Three days after streptozotocin (STZ) injection, rats were divided into six groups: control, diabetic, control and diabetic treated with cobalt chloride, control and diabetics treated with cobalt chloride plus ascorbic acid. 0.5 mM CoCl2 or 0.5 mM CoCl2 plus 1 g/l ascorbic acid were added to their drinking water daily. At the end of the second, fourth and sixth week of the treatment all animals were sacrified by decapitation. Liver and kidney tissues were removed for the determination of nitric oxide (NO) levels. Cobalt treatment effectively decreased the nitric oxide levels both in liver and kidney tissues of diabetic rats. Thus, the effect of oral administration of cobalt treatment may prove effective in improving the impaired nitrite status during the early stage of diabetes and ascorbic acid supplementation at this dose (1g/l) potentiates the effectiveness of cobalt action

🔖

Cite This Article

YILDIRIM, Ö. (2010). COBALT AND ASCORBIC ACID TREATMENT: EFFECTS ON TISSUE NITRIC OXIDE LEVELS IN STREPTOZOTOCIN- DIABETIC RAT. Communications Faculty of Sciences University of Ankara Series C Biology, Cilt: 22 - Sayı: 1, 1–14. https://ajindex.com/articles/247967

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Abrams MJ, Murrer BA (1993). Metal compounds in therapy and diagnosis. Scien. 261: 725- 730. Baynes JW, Thorne S (1999). Role of oxidative stress diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9.
  2. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990). Apparent hydroxyl radical production by peroxiynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Nat. Acad. Scien. USA, 87: 1620–1624.
  3. Behrens WA, Madere R (1991). Vitamin C and vitamin E status in the spontaneously diabetic BB rat before the onset of diabetes. Metabol. 40(1): 76. Braman RS, Hendrix SA (1989). Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal. Chem. 61: 2715-2718.
  4. Brichard SM, Henquin JC (1995). The role of vanadium in the management of diabetes. TiPS 16: 265-270.
  5. Bucala R, Tracey KJ, Cerami A (1991). Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J. Clin. Invest. 87: 432-438.
  6. Corbett JA, Mikhael A, Shimizu J, Frederick K, Misco TP, McDaniel ML, Kanagawa O (1993). Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and resistant stages in the immunological diabetic process. Proc. Nat. Acad. Scien. USA 90: 8992 Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal.Bioch. 126: 131-138.
  7. Grisham MB, Jourd-Heuil D, Wink DA (1999). Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276: G315–21. Guevara I, Iwanejko J, Dembinska-Kiec A, Pankiewicz J, Wanat A, Anna P, Golabek I, Bartus S, Malczewska-Malec M, Szczudlik A (1998).Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta 274: 177-188.
  8. Halliwell B (1997). Antioxidant and human disease: a general introduction. Nut. Rev. 55(1): S44-S52. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Nat. Acad. Scien.USA 84 (24): 9265–9269.
  9. Ischiropoulos H, Zhu L, Beckman JS (1992). Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Bioch. Biophy. 298 (2): 446–451.
  10. Kruszyna H, Megyar JS, Rochelle LG, Russell MA, W